Xcout IntelBioxodes competitors & alternatives
The 12 closest competitors and alternatives to Bioxodes among biotechnology companies — ranked by similarity to what Bioxodes actually does, not by market-cap band.
Subscribe to see Bioxodes’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Bioxodes
Bioxodes is a Belgian clinical-stage biotechnology company founded in 2013 and located in Gosselies. The firm focuses on developing breakthrough treatments for hemorrhagic stroke patients.
Bioxodes at a glance
Bioxodes is a biotechnology company headquartered in Belgium. Its most recent funding round, Series A, raised $5.5M in December 2025. Xcout tracks 9 named people at Bioxodes, including Didier Le Normand (Chief Financial Officer, Consultant).
Bioxodes leadership
- Didier Le NormandChief Financial Officer, Consultant
- Hans WarrinnierChief Medical Officer
- Marc DechampsManaging Director
- Tomas ComblainHead of Finance
- Philippe MonteyneChairman
- Marc DechampsManaging Director
3 more named people on record for Bioxodes, with roles, board committees and tenure — see the full roster →
Bioxodes funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5.5M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Bioxodes competitors
Ranked by semantic similarity — how close each company is to Bioxodes by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
EPICS Therapeutics is a clinical-stage biotechnology company headquartered in Gosselies, Belgium, dedicated to drug discovery and development for small molecule drugs. The company pioneers targeted therapies focusing on RNA epigenetic regulation to transform cancer treatment.
Similar biotechnology company
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Healthcare Biotech
HemostOD is a preclinical-stage biotech company based in Lausanne, Switzerland, pioneering the ex vivo manufacturing of donor-free, off-the-shelf universal human blood platelets to save lives.
BioTech
Acticor Biotech is a clinical-stage biopharmaceutical company headquartered in Paris, France, that specializes in developing innovative treatments for acute thrombotic diseases.
Biotech
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in phase I/II clinical study for the treatment of Huntington’s disease. The company also develops AMT-260, which is in phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Similar biotechnology company
Novadip Biosciences is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in Belgium, focusing on innovative tissue regeneration and biopharmaceuticals.
Similar biotechnology company
TargED Biopharmaceuticals is a Netherlands-based biotechnology company that develops first-class biological drugs to improve the treatment of thrombosis. The company utilizes small antibodies to deliver enzymes directly to blood clots, aiming to provide targeted thrombolysis for patients suffering from various thrombotic disorders.
Similar biotechnology company
Coave Therapeutics is a clinical-stage biotechnology company headquartered in Paris, France. The company focuses on developing life-changing gene therapies targeting rare ocular and central nervous system diseases.
Similar biotechnology company
Celyad Oncology is a biopharmaceutical company headquartered in Mont-Saint-Guibert, Belgium, focused on the development of innovative therapies.
Similar biotechnology company
Cayuga Biotech is a biotechnology company developing novel therapies to address life-threatening hemorrhage by harnessing the body's innate ability to stop bleeding.
Similar biotechnology company
Axonis Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, focused on discovering and developing novel treatments for neurological conditions and spinal cord injuries. Founded in 2019, the company advances therapeutic candidates through its proprietary research platform.
Biotech
Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Bioxodes and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Bioxodesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →